/Research Database
← Research Database
Sehr niedrig2025

The binding mechanism of a novel ferrous ion chelating peptide from chicken blood hemoglobin and the bioavailability of the chelate.

Hanyu Guo, Ying Zhou, Cancan Luo, Zhiyu Li et al.

Kernaussage

A novel ferrous ion-chelating peptide, TAEDKKLIQ, isolated from chicken blood hemoglobin, demonstrated superior thermal and pH stability, digestive resistance, and iron retention compared to conventional iron supplements in the presence of dietary inhibitors, along with low cytotoxicity in Caco-2 cells, suggesting its potential as a safe and effective iron fortifier.

Abstract

In this study, chicken blood hemoglobin hydrolysates were subjected to separation and purification. A novel peptide (TAEDKKLIQ) with high ferrous ion chelating activity was identified from chicken blood hemoglobin hydrolysate. The binding mechanism between TAEDKKLIQ and ferrous ions was elucidated using a combination of structural characterization, molecular docking, and molecular dynamics simulation. The results indicated that TAEDKKLIQ formed a monodentate coordination bond with ferrous ions via the carboxyl group on the Asp side chain, exhibiting a single binding site. Furthermore, the stability and cellular activity experiments demonstrated that TAEDKKLIQ-Fe not only exhibited good chemical stability but also surpassed lactoferrin, the conventional iron supplement, in cellular activity. This study provided new scientific evidence for the application of peptides derived from chicken blood in food processing and nutritional fortification systems, and provided theoretical support for developing highly efficient and safe peptide-based iron supplements.

Kein medizinischer Rat. Die dargestellten Studien dienen der wissenschaftlichen Information und ersetzen keine ärztliche Beratung. Bei gesundheitlichen Fragen wende dich an eine approbierte Ärztin oder einen Arzt.

Quelle: PubMed Central / National Library of Medicine (NLM). Apollion steht in keiner Verbindung mit NLM und wird von NLM nicht empfohlen. Evidenzgrade bewerten die methodische Studienqualität — nicht die inhaltliche Richtigkeit.

Lizenz: CC BY — Inhalte werden ausschließlich aus Open-Access-Quellen mit kommerziell nutzbaren Lizenzen (CC0, CC BY, CC BY-SA) indexiert.